The Oncology Institute, Inc.

NasdaqCM:TOI

Market Cap

USD 231.62 M

Share Price

USD 2.52

Avg Daily Volume

1,410,387

Change (1 day)

3.28%

Change (1 year)

Change (YTD)

251.91%

The Oncology Institute, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -15.96%

The Oncology Institute, Inc. Net Income Margin is -15.96% for the Trailing 12 Months (TTM) ending March 31, 2025, a -25.01% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.
  • The Oncology Institute, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -21.29%, a 18.51% change year over year.
  • The Oncology Institute, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -17.96%, a -502.44% change year over year.
  • The Oncology Institute, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 4.46%, a -235.35% change year over year.
  • The Oncology Institute, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -3.30%.
Key Data
Date Net Income Margin EBT Margin Operating Income Margin Gross Profit Margin